Navigation Links
Higher Vitamin D Intake Could Cut Cancer Risk
Date:2/28/2011

SUNDAY, Feb. 27 (HealthDay News) -- A new study says it takes far more vitamin D than initially thought to dramatically cut the risk of several major diseases, including breast cancer.

"We found that daily intakes of vitamin D by adults in the range of 4,000-8,000 IU are needed to maintain blood levels of vitamin D metabolites in the range needed to reduce by about half the risk of several diseases -- breast cancer, colon cancer, multiple sclerosis and type 1 diabetes," study co-author Dr. Cedric Garland, a professor of family and preventive medicine at the University of California at San Diego, said in a university news release.

Garland admitted that he was surprised that the levels required were so much higher than the 400 IU a day needed to vanquish rickets in the 20th century.

Vitamin D supplements often come in pills or capsules containing 1,000 or 2,000 international units. But 4,000 to 8,000 IU a day is still much lower than the range considered safe by the National Academy of Science's Institute of Medicine, the researchers noted.

The study -- which also involved the Creighton University School of Medicine in Omaha -- was based on a survey of several thousand people who took supplements ranging from 1,000 to 10,000 IU per day. The volunteers also underwent blood tests to determine the levels of vitamin D metabolites circulating in their blood.

Some studies suggest that only 10 percent of people in the United States have the appropriate level of the vitamin D-related form in their blood to prevent disease linked to a deficiency of the vitamin. These people tend to work outdoors, where their vitamin D levels are boosted through sun exposure.

Last year, a National Academy of Sciences Institute of Medicine (IOM) committee announced that 4,000 IU a day of vitamin D appears safe for adults and kids aged 9 and up.

The IOM's recommended minimum daily level is 600 IU, however, and the Institute not
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Elderly drivers have higher crash rates in non problematic environments than other drivers
2. The Association for Gerontology in Higher Education honors new officers, awardees
3. Higher vitamin D intake needed to reduce cancer risk
4. People With Bowel Disease at Higher Risk of Blood Clot in Lungs, Legs
5. Higher volume reduces false positives in screening mammography
6. Higher levels of social activity decrease the risk of developing disability in old age
7. Method of DNA repair linked to higher likelihood of genetic mutation
8. In-Hospital Blood Sugar Levels Should Be Higher: Report
9. Could Hair Loss at 20 Signal Higher Prostate Cancer Risk?
10. Higher Levels of Blood Protein Linked to Lower Respiratory Risks
11. Birth Defect Risk Slightly Higher for Kids of Male Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Higher Vitamin D Intake Could Cut Cancer Risk
(Date:5/21/2013)... May 21 (HealthDay News) -- Urban elementary school ... experience sleep problems and suffer academically, new research ... aged seven to nine, we found that compromised ... and impaired academic performance," said study author ... human behavior at Brown University,s Alpert Medical School ...
(Date:5/21/2013)... Minn. Positively charged gold nanoparticles are usually ... to avoid nanoparticle toxicity. Mayo Clinic researchers found ... nanoparticles effective against ovarian cancer cells. The discovery ... the Journal of Biological Chemistry ., "This ... cancer cells by preventing the cell death or ...
(Date:5/21/2013)... May 21, 2013 Representatives with Hammerhead Bicycles ... a success that the company has achieved its overall goal ... day one was to move Hammerhead Bicycles from a house ... President Scott Robertson. , Robertson explained that the bike shop ... to exclusively focus on all things 29er and 650b. ...
(Date:5/21/2013)... the sound of galloping hooves behind you, your immediate reaction ... it is actually a zebra approaching. Doctors are trained to ... their practices, and as they rarely or never meet a ... takes many years to reach the right diagnosis. A new ... many cases. , Ole Winther is Associate Professor at ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Two-thirds of ... non-small cell lung cancer reported that they engage in ... medicine use, according to new findings from the ... Kantar Health . The research will be presented ... (International Society for Pharmacoeconomics and Outcomes Research) in New ...
Breaking Medicine News(10 mins):Health News:Sleepless Nights May Hurt School Performance of Kids With Asthma 2Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:New search engine finds rare diagnoses 2Health News:New search engine finds rare diagnoses 3Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3
... (ASX: PGL; Nasdaq: PGLA) announced today that its ... status by the U.S. Food,and Drug Administration (FDA). ... 88 for the prevention of tumor recurrence following ... primary liver,cancer). Under the FDA Modernization Act ...
... Urgent Health Problems Report Highest Satisfaction When Seen by ... , Patient satisfaction with after-hours care for an urgent ... physician or their physicians after-hours clinic, compared with a ... services. According to a survey of 1,227 patients from ...
... seldom questioned, study found , , MONDAY, Sept. 24 (HealthDay ... some of their neediest patients, a new study suggests ... that raise suicide risk. , U.S. researchers recruited ... showing signs of depression or a similar disorder. , ...
... for her contributions to kidney ... ... a nationwide patient advocacy group comprised of more than 20,000,dialysis and pre-dialysis ... Entitled, Celebrating the Empowerment of,Kidney Patients, the event brought together dialysis patients ...
... N.C., Sept. 24 SalesForce4Hire(R), a provider of,custom ... Science industries,today announced the opening of its new ... allows SalesForce4Hire to expand its custom sales focus ... size of its sales,support call center. This new ...
... Robust Clinical Data Package Provided in NDA Demonstrates ... Safety of Once-Daily Tramadol Formulation, LAVAL, QC, Sept. ... announced that is has requested a meeting with the ... Drug,Application (NDA) for its once-daily formulation of tramadol. Based ...
Cached Medicine News:Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 2Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 3Health News:September/October 2007 Annals of Family Medicine tip sheet 2Health News:September/October 2007 Annals of Family Medicine tip sheet 3Health News:September/October 2007 Annals of Family Medicine tip sheet 4Health News:September/October 2007 Annals of Family Medicine tip sheet 5Health News:September/October 2007 Annals of Family Medicine tip sheet 6Health News:September/October 2007 Annals of Family Medicine tip sheet 7Health News:Doctors Often Fail to Spot Suicidal Patients 2Health News:Doctors Often Fail to Spot Suicidal Patients 3Health News:Nation's Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care 2Health News:Nation's Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care 3Health News:SalesForce4Hire Opens New Office 2Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 2Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 3
(Date:5/21/2013)... Calif. , May 21, 2013 Abaxis, ... blood analysis systems, announced today that Martin ... at the Stifel Annual Dental & Veterinary Conference on ... conference will be held at Le Parker Meridien Hotel ... About Abaxis Abaxis develops, manufactures, markets ...
(Date:5/21/2013)... JUPITER, Fla. , May 21, 2013  BioRestorative ... a life sciences company focused on developing stem cell ... Mark Weinreb , its President and CEO, ... The conference will be held on Thursday, ... at 109 E 42nd Street in New York City.  ...
(Date:5/21/2013)... 2013 Ceregene, Inc. today announced additional ... double-blind, randomized, controlled Phase 2b clinical study of ... designed to deliver the neurotrophic factor neurturin, for ... robust response to CERE-120 in Parkinson,s patients diagnosed ... those diagnosed 10 years or more (p<.005), as ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
... Nov. 18, 2010 The Pharmacy Technician ... Melissa Murer Corrigan, will serve as the 2011 president ... be installed at the ICE Annual Education Conference on ... organization that provides educational, networking and advocacy resources for ...
... 2010 Cell Therapeutics, Inc. ("CTI") (Nasdaq and ... Application ("MAA") seeking approval for Pixuvri™ (pixantrone dimaleate) ... relapsed or refractory aggressive non-Hodgkin,s lymphoma ("NHL") was ... Medicines Agency ("EMA"). Validation indicates that the application ...
Cached Medicine Technology:Melissa Murer Corrigan to Serve as 2011 ICE President 2The European Medicines Agency Validates and Accepts Cell Therapeutics' Marketing Authorization Application for Pixuvri™ 2The European Medicines Agency Validates and Accepts Cell Therapeutics' Marketing Authorization Application for Pixuvri™ 3
... a Q-switched ruby laser system ... nm. High Performance Combined with ... combination of high performance and ... mode effectively destroys the (natural ...
A Powerful New Quantitative Immunoassay for Monitoring Bladder Cancer Patients. Useful in Monitoring Patients for,Disease Progression and Recurrence....
... Test is an in vitro immunoassay intended for ... tumor associated antigen. It is indicated for use ... cancer in conjunction with cystoscopy or when prescribed ... by the FDA for prescription home use in ...
... is a quantitative microplate enzyme immunoassay that detects ... have very small amounts of NMP22 protein in ... is often elevated in the urine of patients ... the disease. The use of the NMP22 protein ...
Medicine Products: